Cetera Investment Advisers’s e.l.f. Beauty ELF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Buy
28,178
+6,781
+32% +$412K ﹤0.01% 2352
2026
Q1
$1.3M Sell
21,397
-799
-4% -$65K ﹤0.01% 2672
2025
Q4
$1.69M Buy
22,196
+201
+0.9% +$19.8K ﹤0.01% 2363
2025
Q3
$2.91M Buy
21,995
+575
+3% +$70.9K ﹤0.01% 1853
2025
Q2
$2.67M Sell
21,420
-1,248
-6% -$107K ﹤0.01% 1637
2025
Q1
$1.42M Sell
22,668
-9,810
-30% -$854K ﹤0.01% 1990
2024
Q4
$4.08M Buy
32,478
+918
+3% +$110K 0.01% 1161
2024
Q3
$3.44M Sell
31,560
-7,759
-20% -$1.22M 0.01% 1229
2024
Q2
$8.29M Buy
39,319
+9,939
+34% +$1.77M 0.02% 751
2024
Q1
$5.76M Buy
29,380
+24,425
+493% +$4.34M 0.01% 915
2023
Q4
$715K Buy
4,955
+1,266
+34% +$146K 0.01% 1296
2023
Q3
$405K Buy
3,689
+1,605
+77% +$195K ﹤0.01% 1542
2023
Q2
$238K Buy
+2,084
New +$201K ﹤0.01% 1885

Other funds holding ELF

Cetera Investment Advisers's ELF Position: Q2 2026 in Review

Cetera Investment Advisers increased its e.l.f. Beauty (ELF) stake by 32% in Q2 2026, buying an estimated $412K and bringing the position to 28,178 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

Cetera Investment Advisers first reported a position in ELF in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.29M in Q2 2024. 434 funds tracked by Wall St. Rank hold ELF as of Q2 2026.

  • Cetera Investment Advisers held 28,178 shares of e.l.f. Beauty worth $2.09M as of Q2 2026.
  • Cetera Investment Advisers bought 6,781 e.l.f. Beauty shares in Q2 2026, an estimated $412K.
  • e.l.f. Beauty made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2352 holding.
  • Cetera Investment Advisers first reported a position in e.l.f. Beauty in Q2 2023 and has held it in 13 quarters since.
  • Cetera Investment Advisers's e.l.f. Beauty position peaked at $8.29M in Q2 2024.
  • 434 funds tracked by Wall St. Rank held e.l.f. Beauty as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.